Royce & Associates’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-1,036
| Closed | -$34K | – | 1000 |
|
|
2020
Q2 | $34K | Buy |
1,036
+333
| +47% | +$10.9K | ﹤0.01% | 1076 |
|
|
2020
Q1 | $29K | Buy |
703
+144
| +26% | +$5.94K | ﹤0.01% | 1070 |
|
|
2019
Q4 | $34K | Buy |
559
+44
| +9% | +$2.68K | ﹤0.01% | 1071 |
|
|
2019
Q3 | $38K | Buy |
515
+183
| +55% | +$13.5K | ﹤0.01% | 1080 |
|
|
2019
Q2 | $27K | Sell |
332
-62
| -16% | -$5.04K | ﹤0.01% | 1089 |
|
|
2019
Q1 | $28K | Buy |
394
+48
| +14% | +$3.41K | ﹤0.01% | 1102 |
|
|
2018
Q4 | $16K | Sell |
346
-58
| -14% | -$2.68K | ﹤0.01% | 1124 |
|
|
2018
Q3 | $23K | Buy |
+404
| New | +$23K | ﹤0.01% | 1140 |
|